Schekman tapped as the top editor of a new journal
Randy W. Schekman, a Howard Hughes Medical Institute investigator and editor of the Proceedings of the National Academy of Sciences, will lead the launch of a new open-access journal established by HHMI, the Max Planck Society and the Wellcome Trust.
Schekman, a professor at the University of California, Berkeley, has devoted the past three decades to better understanding the molecular machinery that enables proteins to be trafficked within cells. He has made many contributions in his field, including discovering how vesicles bud off from the cell’s endoplasmic reticulum and transport proteins and identifying more than 50 genes involved in the process with his colleagues.
Schekman’s important role has yielded several major awards, including the Albert Lasker Award for Basic Medical Research, the Gairdner Foundation International Award and the Louisa Gross Horwitz Prize.
Diabetes group’s Banting award goes to Corkey
Barbara E. Corkey, vice-chair of research in the department of medicine at Boston University School of Medicine and director of the Obesity Research Center at Boston Medical Center, received the American Diabetes Association’s 2011 Banting Medal for Scientific Achievement Award.
Named after Nobel Prize winner Frederick Banting, this prestigious award honors an individual who has made significant, long-term contributions to the understanding of diabetes, its treatment or its prevention.
A leader in the fields of metabolism, diabetes and obesity for more than 35 years, Corkey works on the molecular basis of nutrient signal transduction and has significantly improved our understanding of health and disease. She developed the concept of glucolipotoxicity, in which elevated glucose and lipids cause tissue malfunction in diabetes, and found that anaplerosis, malonyl-CoA, reactive oxygen species and long-chain acyl-CoA esters are linked to fuel metabolism and control of insulin secretion in beta cells.
Two JBC board members receive Japanese prizes
Journal of Biological Chemistry editorial board members Kohei Miyazono and Naoyuki Taniguchi were selected to receive the Japan Academy Prize. One of the most prestigious prizes in Japanese academia, the Japan Academy Prize is given to nine recipients who have made great contributions in their respective fields. The recipients come from a wide range of academic fields including humanities, social sciences, formal sciences, natural sciences and applied sciences.
The Japan Academy Prize recognized Taniguchi for his pioneering accomplishments in glycobiology and his discovery of the significance of N-glycans in disease. His current research aims to study glycan-related cancers and infectious diseases through multiple approaches combining glycobiology, chemical biology, structural biology and bioinformatics.